Your browser doesn't support javascript.
loading
Clinical Characterization of Patients Diagnosed with Prostate Cancer and Undergoing Conservative Management: A PIONEER Analysis Based on Big Data.
Gandaglia, Giorgio; Pellegrino, Francesco; Golozar, Asieh; De Meulder, Bertrand; Abbott, Thomas; Achtman, Ariel; Imran Omar, Muhammad; Alshammari, Thamir; Areia, Carlos; Asiimwe, Alex; Beyer, Katharina; Bjartell, Anders; Campi, Riccardo; Cornford, Philip; Falconer, Thomas; Feng, Qi; Gong, Mengchun; Herrera, Ronald; Hughes, Nigel; Hulsen, Tim; Kinnaird, Adam; Lai, Lana Y H; Maresca, Gianluca; Mottet, Nicolas; Oja, Marek; Prinsen, Peter; Reich, Christian; Remmers, Sebastiaan; Roobol, Monique J; Sakalis, Vasileios; Seager, Sarah; Smith, Emma J; Snijder, Robert; Steinbeisser, Carl; Thurin, Nicolas H; Hijazy, Ayman; van Bochove, Kees; Van den Bergh, Roderick C N; Van Hemelrijck, Mieke; Willemse, Peter-Paul; Williams, Andrew E; Zounemat Kermani, Nazanin; Evans-Axelsson, Susan; Briganti, Alberto; N'Dow, James.
Afiliação
  • Gandaglia G; Guidelines Office, European Association of Urology, Arnhem, The Netherlands; Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Hospital, Milan, Italy. Electronic address: Gandaglia.giorgio@hsr.it.
  • Pellegrino F; Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Hospital, Milan, Italy.
  • Golozar A; Odysseus Data Services, New York, NY, USA; OHDSI Center, Northeastern University, Boston, MA, USA.
  • De Meulder B; Association EISBM, Vourles, France.
  • Abbott T; Astellas Pharma, Inc., Northbrook, IL, USA.
  • Achtman A; The Movember Foundation, Melbourne, Australia.
  • Imran Omar M; Guidelines Office, European Association of Urology, Arnhem, The Netherlands; Academic Urology Unit, University of Aberdeen, Scotland, UK.
  • Alshammari T; Riyadh Elm University, Riyadh, Saudi Arabia.
  • Areia C; University of Oxford, Oxford, UK.
  • Asiimwe A; Bayer AG, Berlin, Germany.
  • Beyer K; Translational Oncology and Urology Research, King's College London, London, UK.
  • Bjartell A; Department of Translational Medicine, Lund University, Lund, Sweden.
  • Campi R; Guidelines Office, European Association of Urology, Arnhem, The Netherlands; Unit of Urological Robotic Surgery and Renal Transplantation, University of Florence, Careggi Hospital, Florence, Italy; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Cornford P; Liverpool University Hospitals, Liverpool, UK.
  • Falconer T; Department of Biomedical Informatics, Columbia University, New York, NY, USA.
  • Feng Q; Astellas Pharma, Inc., Northbrook, IL, USA.
  • Gong M; Nanfang Hospital, Southern Medical University, Guangzhou, China; DHC Technologies, Beijing, China.
  • Herrera R; Bayer AG, Berlin, Germany.
  • Hughes N; Epidemiology, Janssen R&D, Belgium.
  • Hulsen T; Philips Research, Department of Hospital Services & Informatics, Eindhoven, The Netherlands.
  • Kinnaird A; University of Alberta, Edmonton, Canada.
  • Lai LYH; University of Manchester, Manchester, UK.
  • Maresca G; Department of Urology, NHS Grampian, Scotland, UK.
  • Mottet N; Guidelines Office, European Association of Urology, Arnhem, The Netherlands.
  • Oja M; Institute of Computer Science, University of Tartu, Tartu, Estonia; STACC, Tartu, Estonia.
  • Prinsen P; Netherlands Comprehensive Cancer Organization, Eindhoven, The Netherlands.
  • Reich C; IQVIA, London, UK.
  • Remmers S; Erasmus University Medical Centre, Cancer Institute, Rotterdam, The Netherlands.
  • Roobol MJ; Erasmus University Medical Centre, Cancer Institute, Rotterdam, The Netherlands.
  • Sakalis V; Department of Urology, General Hospital of Thessaloniki Agios Pavlos, Thessaloniki, Greece.
  • Seager S; RWS, IQVIA, Durham, NC, USA.
  • Smith EJ; Guidelines Office, European Association of Urology, Arnhem, The Netherlands.
  • Snijder R; Astellas Pharma, Inc., Northbrook, IL, USA.
  • Steinbeisser C; Bayer AG, Berlin, Germany.
  • Thurin NH; INSERM CIC-P 1401, Bordeaux PharmacoEpi, Université de Bordeaux, Bordeaux, France.
  • Hijazy A; Association EISBM, Vourles, France.
  • van Bochove K; The Hyve, Utrecht, The Netherlands.
  • Van den Bergh RCN; St Antonius Hospital, Utrecht, The Netherlands.
  • Van Hemelrijck M; Translational Oncology and Urology Research, King's College London, London, UK.
  • Willemse PP; Guidelines Office, European Association of Urology, Arnhem, The Netherlands; Department of Urology, Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Williams AE; The Institute for Clinical Research and Health Policy Studies at Tufts Medical Center, Boston, MA, USA.
  • Zounemat Kermani N; Department of Computing, Data Science Institute, Imperial College London, London, England.
  • Evans-Axelsson S; Bayer AG, Berlin, Germany.
  • Briganti A; Guidelines Office, European Association of Urology, Arnhem, The Netherlands; Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Hospital, Milan, Italy.
  • N'Dow J; Guidelines Office, European Association of Urology, Arnhem, The Netherlands; Academic Urology Unit, University of Aberdeen, Scotland, UK.
Eur Urol ; 85(5): 457-465, 2024 May.
Article em En | MEDLINE | ID: mdl-37414703

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Diabetes Mellitus Tipo 2 Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Eur Urol Ano de publicação: 2024 Tipo de documento: Article País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Diabetes Mellitus Tipo 2 Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Eur Urol Ano de publicação: 2024 Tipo de documento: Article País de publicação: Suíça